Evidence map›Paper›PMID 25569361›Full record

ArticleOtology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology2015

Identification of target proteins involved in cochlear otosclerosis.

Céline Richard, Joni K Doherty, Jose N Fayad, Ana Cordero, Fred H Linthicum

Open access · greenAbstract read
In one paragraph

Article in Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Heterozygous Nonsense Mutation in the Nuclear Transport FactorInternational journal of molecular sciences · 2026
    Article
  2. Exploring the genetic landscape of otosclerosis: current understanding and future perspectives.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2025
    Review
  3. A comparison between endoscopic and microscopic approaches for stapes surgery: experience of a tertiary referral center.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  4. Dynamic Molecular Markers of Otosclerosis in the Human Cochlea.The Annals of otology, rhinology, and laryngology · 2024
    Article
  5. Oxidative stress in otosclerosis.Redox report : communications in free radical research · 2017
    Article
  6. Immunohistochemical techniques for the human inner ear.Histochemistry and cell biology · 2016
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Céline Richard*Otorhinolaryngology Department, Hôpital Nord-Ouest, Villefranche-sur-Saône, France; †Shohet Ear Associates Medical Group, Seal Beach, California; ‡House Clinic, Los Angeles, California; §House Temporal Bone Laboratory, University of California, Los Angeles, California, U.S.A.
Joni K Doherty
Jose N Fayad
Ana Cordero
Fred H Linthicum
Hôpital Nord · FRHouse Clinic · US

Funding

Otopathology by Light Microscopy and Molecular TechniquesU24DC008559 · NIDCD · MASSACHUSETTS EYE AND EAR INFIRMARY · PI MERCHANT, SAUMIL N. · 2006 to 2010
$3.3M
The Otopathology of Hearing Loss: Genotype-Phenotype Correlation in Human TBU24DC011962 · NIDCD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ISHIYAMA, AKIRA, LINTHICUM, FRED H · 2011 to 2015
$2.2M
INHIBITORY &INDUCTIVE SIGNALS OF OLFACTORY NEUROGENESISR03DC001196 · NIDCD · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI KLEIN, STEVEN L · 1991 to 1991
–
NIDCD NIH HHS U24 DC008559NIDCD NIH HHS U24 DC011962NIDCD NIH HHS U24 DC011962H01
6 · The paper itself

Abstract

hypothesisInvestigation of differential protein expression will provide clues to pathophysiology in otosclerosis.

backgroundOtosclerosis is a bone remodeling disorder limited to the endochondral layer of the otic capsule within the temporal bone. Some authors have suggested an inflammatory etiology for otosclerosis resulting from persistent measles virus infection involving the otic capsule. Despite numerous genetic studies, implication of candidate genes in the otosclerotic process remains elusive. We employed liquid chromatography-mass spectrometry (LC-MS) analysis on formalin-fixed celloidin-embedded temporal bone tissues for postmortem investigation of otosclerosis.

methodsProteomic analysis was performed using human temporal bones from a patient with severe otosclerosis and a control temporal bone. Sections were dissected under microscopy to remove otosclerotic lesions and normal otic capsule for proteomic analysis. Tandem 2D chromatography mass spectrometry was employed. Data analysis and peptide matching to FASTA human databases was done using SEQUEST and proteome discoverer software.

resultsTGFβ1 was identified in otosclerosis but not in the normal control temporal bone specimen. Aside from TGFβ1, many proteins and predicted cDNA-encoded proteins were observed, with implications in cell death and/or proliferation pathways, suggesting a possible role in otosclerotic bone remodeling. Immunostaining using TGFβ1 monoclonal revealed marked staining of the spongiotic otosclerotic lesions.

conclusionsMechanisms involved in cochlear extension of otosclerosis are still unclear, but the implication of TGFβ1 is supported by the present proteomic data and immunostaining results. The established role of TGFβ1 in the chondrogenesis process supports the theory of a reaction targeting the globulae interossei within the otic capsule.

Indexed as

Bone RemodelingChondrogenesisChromatography, LiquidCochleaHumansOtosclerosisProteomicsTandem Mass SpectrometryTemporal BoneTransforming Growth Factor beta1TGFB1 protein, humanTransforming Growth Factor beta1

Identifiers

PMID25569361
PMCPMC4431897
OpenAlexW2060506901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.